Categories: aggregated

Pharmaceutical Companies Win Big with Schedule 3 Classification of Cannabis – Desheduling is the Only Way for True Equity

For decades, Joe Biden has been cozy with Big Pharma, accepting millions in campaign contributions from drug companies over his long political career. It’s no secret that the pharmaceutical industry vehemently opposes cannabis legalization, as legal weed represents a major threat to their profits from opiate painkillers and other drugs. Pharma much prefers that cannabis remain illegal, or barring that, placed into a restrictive category like Schedule III that they can control and corner the market on.

Jason

Share
Published by
Jason

Recent Posts

The Red Wall Blocking Marijuana Legalization in America, Real or Imagined?

As the movement for marijuana legalization gains momentum across the United States, a significant barrier…

7 hours ago

Autoimmune Conditions Are Rising Fast in American Medicine, Can Cannabis Help?

Conventional treatments prescribed to treat autoimmune conditions are focused on taming inflammation; these usually include…

7 hours ago

Ohio Non-Medical Cannabis is available at Verilife

Verilife Non-Medical Cannabis is now available in Ohio. Open to customers 21+ with a valid…

1 day ago

Find Verilife in New York

At Verilife, there's always a stocked selection of top products & new favorites. Find the…

1 day ago

Find Verilife in Illinois

At Verilife, there's always a stocked selection of top products & new favorites. Find the…

1 day ago